Celox sent me this report comparing Hemcon and Z-medica with Celox HERE (its a verified safe Pdf download from adrive).
Given the positive results I was left wondering why this product was not the sole choice of the Military, in particular the US forces?
So I emailed Craig Hardy, CEO, MedTrade Products Ltd and asked him........
Me: According to the Jan. ’08 Portsmouth pdf study (comparing Celox with Hemcon and Z-medica’s, Quikclot) the results indicate Celox shows a 100% survival rate. Is this product currently undergoing any evaluation by the military?
Craig: Yes. Celox is used in some performance critical areas of the military and being evaluated in many others. Its an ongoing process.
Me: Given that Medtrade is a U.K. based company what (if any) impact has this had for the uptake of Celox by the U.S. military?
Craig: In the US, Celox is distributed to the Military through Sam Medical in Portland Oregon. The UK is a very close ally of the US. We have heard of no decisions made on the basis of location. However our head office location means we are not as politically connected as some competitors and I believe this may have a significant effect.
2 comments:
100% survival rate huh? That just means it hasn't been used on enough people. OR they aren't using it on serious enough wounds, maybe splinters and papercuts.
^^^^^ If you took the time to read the study, you'd find the wounds were severe, and industry standard. Celox is now saving lives in Afghanistan on a daily basis (please see Pozza and Millner, Journ of Euro Em Med, May 2010).
Or is a peer reviewed study in a well known medical journal, looking at real-life battle wounds not enough for you?
Post a Comment